Thermo Fisher Scientific's Oncomine Dx Express Test, performed on the Ion Torrent Genexus Dx platform, received FDA approval as an in vitro diagnostic assay for the companion diagnostic use with Dizal's Zegfrovy (sunvozertinib) in non-small cell lung cancer patients harboring EGFR exon 20 insertion mutations. This approval facilitates rapid next-generation sequencing in decentralized clinical settings, enhancing molecularly guided treatment approaches.